Literature DB >> 10420063

Value of screening instruments in the diagnosis of post-stroke dementia.

I de Koning1, F van Kooten, P J Koudstaal.   

Abstract

Brief dementia screening instruments, or mental status tests are frequently used to screen for cognitive impairment. We discuss the strengths and weaknesses of existing mental status tests in dementia screening in general. Most screening instruments that are used in clinical practice are developed to detect dementia compatible with Alzheimer's disease, and their value in detecting dementia after stroke is less well known. A stroke may cause both cortical and subcortical deficits, and the clinical expression of post-stroke dementia is different from that of Alzheimer's disease. Existing brief mental status tests have limited value in this patient group because they tend to ignore specific problems which may occur in stroke patients. Some expanded screening instruments, like the CAMCOG, are more useful and have additional diagnostic value. With the growing interest in research for vascular factors in dementia over the past years, however, a specific screening instrument for post-stroke dementia would be a valuable contribution.

Entities:  

Mesh:

Year:  1998        PMID: 10420063     DOI: 10.1159/000022427

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  3 in total

Review 1.  A review of screening tests for cognitive impairment.

Authors:  Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

2.  Post-stroke cognitive impairments.

Authors:  N V Vakhnina; L Yu Nikitina; V A Parfenov; N N Yakhno
Journal:  Neurosci Behav Physiol       Date:  2009-10

3.  A hybrid intelligent diagnosis approach for quick screening of Alzheimer's disease based on multiple neuropsychological rating scales.

Authors:  Ziming Yin; Yinhong Zhao; Xudong Lu; Huilong Duan
Journal:  Comput Math Methods Med       Date:  2015-03-01       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.